94 related articles for article (PubMed ID: 26785111)
21. Treatment of Childhood T-Cell Lymphoblastic Lymphoma-Long-Term Results of the SFOP LMT96 Trial.
Bergeron C; Coze C; Segura C; Pacquement H; Gandemer V; Ducassou S; Patte C;
Pediatr Blood Cancer; 2015 Dec; 62(12):2150-6. PubMed ID: 26248696
[TBL] [Abstract][Full Text] [Related]
22. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
23. Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda.
Tapela NM; Mpunga T; Hedt-Gauthier B; Moore M; Mpanumusingo E; Xu MJ; Nzayisenga I; Hategekimana V; Umuhizi DG; Pace LE; Bigirimana JB; Wang J; Driscoll C; Uwizeye FR; Drobac PC; Ngoga G; Shyirambere C; Muhayimana C; Lehmann L; Shulman LN
BMC Cancer; 2016 Mar; 16():237. PubMed ID: 26992690
[TBL] [Abstract][Full Text] [Related]
24. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
25. Treatment of nephroblastoma in Africa: results of the first French African pediatric oncology group (GFAOP) study.
Moreira C; Nachef MN; Ziamati S; Ladjaj Y; Barsaoui S; Mallon B; Tournade MF
Pediatr Blood Cancer; 2012 Jan; 58(1):37-42. PubMed ID: 21850676
[TBL] [Abstract][Full Text] [Related]
26. Bubble CPAP to support preterm infants in rural Rwanda: a retrospective cohort study.
Nahimana E; Ngendahayo M; Magge H; Odhiambo J; Amoroso CL; Muhirwa E; Uwilingiyemungu JN; Nkikabahizi F; Habimana R; Hedt-Gauthier BL
BMC Pediatr; 2015 Sep; 15():135. PubMed ID: 26403679
[TBL] [Abstract][Full Text] [Related]
27. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
28. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
29. Cancer incidence, morbidity, and survival in Canadian first nation children: a Manitoba population-based study from the cancer in young people in Canada (CYP-C) registry.
Stammers DM; Israels SJ; Lambert PJ; Cuvelier GD
Pediatr Blood Cancer; 2014 Dec; 61(12):2164-9. PubMed ID: 24616082
[TBL] [Abstract][Full Text] [Related]
30. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
[TBL] [Abstract][Full Text] [Related]
31. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
Tebbi CK; Mendenhall N; London WB; Williams JL; de Alarcon PA; Chauvenet AR;
Pediatr Blood Cancer; 2006 Feb; 46(2):198-202. PubMed ID: 16136581
[TBL] [Abstract][Full Text] [Related]
32. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
33. HIV antibodies in a remote rural area in Rwanda, Central Africa: an analysis of potential risk factors for HIV seropositivity.
Van de Perre P; Le Polain B; Carael M; Nzaramba D; Zissis G; Butzler JP
AIDS; 1987 Dec; 1(4):213-5. PubMed ID: 3126767
[TBL] [Abstract][Full Text] [Related]
34. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
35. Treating Pediatric soft tissue sarcomas in a country with limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala.
Antillon F; Castellanos M; Valverde P; Luna-Fineman S; Garrido C; Serrato T; Rodriguez-Galindo C; Casanova M; Ferrari A
Pediatr Blood Cancer; 2008 Dec; 51(6):760-4. PubMed ID: 18680154
[TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
37. Treatment strategies in childhood cancer.
Alcoser PW; Rodgers C
J Pediatr Nurs; 2003 Apr; 18(2):103-12. PubMed ID: 12720207
[TBL] [Abstract][Full Text] [Related]
38. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
39. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
40. Soil-transmitted helminths in southern highland Rwanda: associated factors and effectiveness of school-based preventive chemotherapy.
Staudacher O; Heimer J; Steiner F; Kayonga Y; Havugimana JM; Ignatius R; Musemakweri A; Ngabo F; Harms G; Gahutu JB; Mockenhaupt FP
Trop Med Int Health; 2014 Jul; 19(7):812-24. PubMed ID: 24750543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
